Latest filing published 15 Oct 2026 for MapLight Therapeutics, Inc., €80k.
Insider track record
Lillie James Woodruff: trading record in brief
All filings by Lillie James Woodruff on record concern MapLight Therapeutics, Inc. In total, 3 filings cover trades dated from 15 July 2026 to 15 October 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 15 October 2026, the filings show a transaction worth €80k in MapLight Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Lillie James Woodruff
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 11,513 shares@ US$7.81CommonSEC144:0001974158-26-000104
- 22,082 shares@ US$13.020.047% mcap10.0% of flowCommonSEC144:0001974158-26-000093
- 18,835 shares@ US$37.910.12% mcap25.1% of flowCommonSEC144:0001974158-26-000078
3 of 3 declarations